I-140 Final-Stage Wait Holds Steady at 17 Days as Active Backlog Doubles
The weekly completion median has returned to near long-run averages after a mid-June elevation, but the pool of pending cases across tracked filing-month groups has grown by 103% in 81 days, a forward-looking signal worth watching.
For the week of July 20, the I-140 final-stage wait settled at 17 days, one day below last week and essentially flat against the 16-day figure from the same week in 2025. The 8-week regression slope is -0.8 days per week with an R² of 0.06, well below the threshold for a directional claim. The calm in completion times, however, runs alongside a less settled picture in the pipeline: total active pending cases across tracked filing-month groups rose from roughly 20,533 to 41,762 between early May and late July, a 103% increase in 81 days. That accumulation has not yet moved the final-stage median, but it is the number that defines the outlook.
- The 17-day final-stage median for the week of July 20 is 1 day below last week and matches the 3-year same-week average of 16 days.
- The 8-week slope of -0.8 days per week carries an R² of 0.06, too weak to support a directional claim; the pattern is classified as noisy and stable.
- Total active pending cases across tracked filing-month groups rose 103% in 81 days, from roughly 20,533 to 41,762, with the June 2026 filing-month group contributing 10,068 active cases.
- RFE (Request for Evidence)-stamped cases cleared in 29 days this week, 6 days slower than the 23-day median for plain-processing cases.
- The 4-week forecast band runs ~9 to 33 days for the week of July 27, reflecting the near-zero R² of the current regression fit.
A quiet finish, for now
This week's 17-day median is 7 days below the 12-week trailing average of 24 days, which was elevated by a stretch of higher readings in late June. The 8-week regression slope is -0.8 days per week, but the R² of 0.06 is far below the 0.40 threshold for a meaningful directional signal, so no trend claim is warranted. The week-over-week drop of 1 day (from 18 to 17) is similarly noise-level. The headline number, in short, is unremarkable, and that stability itself is worth noting given what is building in the pipeline.
The W26 spike in the rear-view mirror
Over the past 12 weeks, the median oscillated between 17 and 23 days from early May through mid-June before rising to 41 days in the week of June 22 (W26) and 32 days the following week. The W26 reading was roughly double the preceding weeks' pace. Since then, the median has retraced fully, reaching 20 days in W28 and 17 days this week. What caused the W26 elevation is not identifiable from this data alone; the data brief does not distinguish among possible mechanisms such as a batch of older cases clearing, a routing change, or a temporary volume shift.
The spike also widened the interquartile range (the spread between the 25th percentile, p25, and the 75th percentile, p75) noticeably. In most weeks the p75 runs between 54 and 69 days, but in W26 it reached 102 days, meaning a quarter of cases that week waited at least 102 days from their last reported status to approval. That stretched tail has since compressed: this week's p75 is 69 days and the p25 is 13 days. The median, then, conceals a distribution that can widen quickly, even in weeks where the central reading looks calm.
103% more cases in the pipeline
The more consequential development this week is not in the completion times but in the volume of cases still waiting. Total active pending cases across tracked filing-month groups rose from roughly 20,533 to 41,762 between May 7 and July 27, a 103% increase in 81 days. The June 2026 filing-month group (a cohort (a group of cases), meaning all cases filed in that same calendar month) is the largest single contributor, with 10,068 active cases out of a group total of 15,122. Cohort (filing-month group) approval rates for the most recent months range from 33.1% for the June group to 41.6% for May, meaning the majority of the 2026 intake wave is still awaiting the adjudication (USCIS's case-decision step: approval, denial, or a request for more information) step. If the pace of approvals does not scale with the rate of new filings, final-stage medians may rise in coming months, though the current data does not confirm that shift.
Comparing the February 2026 filing-month group (25 weeks old, 58.5% cleared) to the June 2026 group (8 weeks old, 33.1% cleared) requires an age adjustment before drawing any conclusion: older groups have had more time to accumulate approvals by definition. The week-8 approval rate for the February group is not available in this dataset, so a direct same-age rate comparison cannot be made. What the data does show clearly is a volume difference: the June 2026 group's 15,122 total cases is nearly triple the size of the February group's 17,433 cases filed across the entire month, and the June group is only at week 8 of its clearance curve. That scale, not any sign of slower individual-case processing, is the forward-looking signal.
Preview
Unlock the full analysis for your case
See the complete outlook, a personalised lookup against this week's cohort, and your estimated approval window.
- Full premium analysis: outlook, what it means for you, and implications.
- Personalised case lookup against this week's cohort, with percentile and remaining days.
- Estimated approval window mapped to your filing date.
Cancel anytime. Plans from $5.99/month.